| Many Peaks Minerals Limited (MPK) ORDINARY FULLY PAID |
Materials |
$132 |
Initial RC Scout Drilling Returns Gold at Odienne
|
5 Aug 2025 8:55AM |
$0.680 |
$0.965 |
risen by
41.91%
|
|
MPK - Price-sensitive ASX Announcement
Full Release
Key Points
- Many Peaks Minerals Limited completed initial RC scout drilling at the Odienne Project in Côte d'Ivoire.
- 18 RC holes totaling 1,498 meters were drilled at the Odienne South Prospect.
- Significant gold mineralization was intersected, including 10m at 1.33 g/t gold and 12m at 1.00 g/t gold.
- Gold was found at shallow depths across approximately 1 km strike length.
- Results confirm a mineralized system warranting further exploration.
- Follow-up drilling is planned to expand the known gold mineralization.
- The announcement includes updates on other exploration activities in the region.
- MPK continues to advance its West African gold exploration portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$240 |
Strike Extensions to Nyungu Central Deposit
|
5 Aug 2025 8:55AM |
$0.180 |
$0.295 |
risen by
63.89%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- Prospect Resources Limited (PSC) announced strike extensions to the Nyungu Central deposit.
- Recent drilling has increased the strike length of known copper mineralisation.
- Exploration included diamond and reverse circulation drilling techniques.
- Drill results confirm mineralisation persists at depth and along strike.
- Additional drilling is planned to test the full extent of mineralisation.
- The development supports the potential for a substantial copper resource at Nyungu Central.
- The announcement is part of PSC's broader Kalahari Copper Belt strategy.
- The company aims to build a portfolio of high-value copper assets in the region.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$237 |
Investor Presentation
|
5 Aug 2025 8:53AM |
$0.010 |
$0.029 |
risen by
190%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$408 |
Update - Notification of buy-back - RG8
|
5 Aug 2025 8:49AM |
$1.990 |
$2.830 |
risen by
42.21%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
5 Aug 2025 8:48AM |
$1.715 |
$1.950 |
risen by
13.70%
|
|
| Mac Copper Limited (MAC) ORDINARY FULLY PAID |
Materials |
- |
Dispatch of Scheme Circular
|
5 Aug 2025 8:45AM |
$18.500 |
$18.520 |
risen by
0.11%
|
|
| Hot Chili Limited (HCH) ORDINARY FULLY PAID |
Materials |
$356 |
Hot Chili Non-Renounceable Entitlement Offer Document
|
5 Aug 2025 8:45AM |
$0.580 |
$1.760 |
risen by
203.45%
|
|
HCH - Price-sensitive ASX Announcement
Full Release
Key Points
- Hot Chili Limited is offering a non-renounceable entitlement offer to eligible shareholders.
- Shareholders can subscribe for 1 new share for every 24 existing shares held at a specified issue price.
- The offer is non-renounceable, meaning rights cannot be traded or transferred.
- The funds raised will be used mainly to progress the Costa Fuego Copper-Gold Project in Chile, for exploration, and for working capital.
- The offer is not underwritten.
- The document details the timetable, eligibility criteria, and instructions for participating in the entitlement offer.
- Risks related to the offer, the company’s operations, and investment in shares are comprehensively discussed.
- Taxation implications for shareholders are outlined.
- The document includes a summary of the company, its strategy, and recent developments.
- Potential dilution effects and the rights attached to the new shares are explained.
- No forecast financial information is provided.
- Directors’ interests, intentions, and recommendations regarding the offer are disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Torque Metals Limited (TOR) ORDINARY FULLY PAID |
Materials |
$262 |
Fifteen DHEM Conductor Plates Identified at Paris
|
5 Aug 2025 8:40AM |
$0.235 |
$0.420 |
risen by
78.72%
|
|
TOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Fifteen strong down-hole electromagnetic conductor plates identified at Paris prospect.
- Conductor plates are interpreted as possible massive sulphide mineralization.
- DHEM surveys were conducted over several diamond drillholes.
- The plates correlate with already intersected nickel sulphide zones.
- Results suggest an extensive mineralized system at depth and along strike.
- Follow-up drilling is planned to test the conductor plates.
- The Paris Gold Project is located in Western Australia.
- Findings highlight significant nickel-copper-cobalt exploration potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,449 |
BKI July 2025 NTA & Monthly Report
|
5 Aug 2025 8:38AM |
$1.825 |
$1.795 |
fallen by
1.64%
|
|
| Codan Limited (CDA) ORDINARY FULLY PAID |
Information Technology |
$7,330 |
Notification of Earnings Call
|
5 Aug 2025 8:38AM |
$21.070 |
$40.300 |
risen by
91.27%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$266,750 |
Items impacting CBA's financial reporting
|
5 Aug 2025 8:38AM |
$174.930 |
$159.400 |
fallen by
8.88%
|
|
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$31,076 |
Update - Notification of buy-back - ALL
|
5 Aug 2025 8:36AM |
$68.720 |
$51.530 |
fallen by
25.01%
|
|
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$258 |
Boundiali JORC Resource Grows over 50% to 2.41Moz gold
|
5 Aug 2025 8:36AM |
$0.475 |
$0.640 |
risen by
34.74%
|
|
AUE - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurum Resources Limited announces a 50% increase in Boundiali JORC Mineral Resource Estimate to 2.41Moz gold.
- Updated MRE is based on recent drilling and covers BD and BB prospects in Côte d'Ivoire.
- Total Indicated and Inferred Resource now stands at 63Mt at 1.2g/t Au.
- Resource growth attributed to successful drilling with deposits remaining open along strike and at depth.
- Exploration upside highlighted with further drilling planned for resource expansion.
- Comprehensive details provided on geology, drilling, estimation methods, and project upside.
- Aurum Resources positions itself as a leading gold exploration company in West Africa.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,607 |
Green Bay environmental approval and metallurgical results
|
5 Aug 2025 8:35AM |
$1.045 |
$2.090 |
risen by
100%
|
|
FFM - Price-sensitive ASX Announcement
Full Release
Key Points
- FireFly Metals Ltd received environmental approval for its Green Bay Project in Newfoundland, Canada.
- The approval allows for an underground exploration program, marking a significant milestone for project advancement.
- The company reported positive metallurgical results, indicating high copper recoveries and production of a clean copper concentrate.
- Metallurgical test work supports the technical viability of the Green Bay Copper-Gold Project.
- FFM emphasizes a responsible and sustainable approach to environmental management throughout the project.
- The approvals and results reinforce FFM's confidence in the commercial and operational prospects of Green Bay.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$1,702 |
EOS secures order for 100kW high power laser weapon (A$125m)
|
5 Aug 2025 8:35AM |
$2.950 |
$8.820 |
risen by
198.98%
|
|
EOS - Price-sensitive ASX Announcement
Full Release
Key Points
- EOS secures a contract worth A$125 million for a 100kW high power laser weapon system.
- The contract involves the delivery, integration, and support of directed energy weapon technology.
- The customer is a government entity; delivery milestones are set over a 24-month period.
- This order underlines the maturity and competitiveness of EOS's directed energy weapon solutions.
- The system is designed for counter-drone and counter-missile defense applications.
- The contract is expected to generate significant revenue and reinforce EOS's international standing.
- EOS emphasizes the strategic significance of this order in establishing leadership in advanced defense technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Teaminvest Private Group Limited (TIP) ORDINARY FULLY PAID |
Financials |
$32 |
Update - Notification of buy-back - TIP
|
5 Aug 2025 8:35AM |
$1.750 |
$1.190 |
fallen by
32%
|
|
| Platinum International Fund (Quoted Managed Hedge Fund) (PIXX) |
Financials |
$72 |
PMC:Scheme Withdrawal, Buy-back Meeting Proceeds, L1Proposal
|
5 Aug 2025 8:34AM |
$5.230 |
$5.030 |
fallen by
3.82%
|
|
| Platinum Capital Limited (PMC) ORDINARY FULLY PAID |
Financials |
- |
Scheme Withdrawal, Buy-back Meeting Proceeds, L1 Proposal
|
5 Aug 2025 8:34AM |
$1.415 |
$1.765 |
risen by
24.73%
|
|
PMC - Price-sensitive ASX Announcement
Full Release
Key Points
- PMC has withdrawn the scheme of arrangement and cancelled the buy-back meeting.
- The decision followed advice from the Takeovers Panel.
- The board considered the L1 proposal but chose not to proceed with the buy-back or scheme.
- The scheduled scheme meeting will not be held.
- PMC will continue to focus on maximizing shareholder value.
- The board has responded to L1 Capital and will continue to engage on alternative proposals.
- PMC emphasized transparency and regulatory compliance concerning the buy-back meeting proceeds.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$130 |
FY25 Corporate Governance Statement
|
5 Aug 2025 8:34AM |
$1.650 |
$2.600 |
risen by
57.58%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$130 |
FY25 Appendix 4G
|
5 Aug 2025 8:33AM |
$1.650 |
$2.600 |
risen by
57.58%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$130 |
FY25 Full Year Results Presentation
|
5 Aug 2025 8:33AM |
$1.650 |
$2.600 |
risen by
57.58%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitrafy Life Sciences Limited reported its FY25 Full Year Results.
- The company commercialized its patented cryopreservation technology for pharmaceutical, biotechnology, and medical research clients.
- Expanded distribution agreements and successful product deployments were achieved.
- Vitrafy secured new revenue streams through contracts and partnerships.
- Key regulatory milestones and ongoing clinical trials were highlighted.
- Strategic focus for FY26 includes R&D investment, regulatory progress, and global expansion.
- Financial results showed revenue growth and disciplined operational spending.
- Positioned for accelerated growth and broader market adoption in the next fiscal year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$130 |
FY25 Appendix 4E and Annual Report
|
5 Aug 2025 8:32AM |
$1.650 |
$2.600 |
risen by
57.58%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitrafy Life Sciences Limited specializes in advanced cryopreservation technologies for the life sciences sector.
- The company continued to invest heavily in research and development throughout the FY25 reporting period.
- There was an increase in operating expenses, primarily due to scaling business operations and expanding technical capabilities.
- VFY reported a net loss for the year, consistent with its growth phase and ongoing development activities.
- The annual report details investments in intellectual property and highlights progress in product development.
- Corporate governance, risk management, and board structures are comprehensively addressed.
- The company outlines plans for international expansion and forging strategic partnerships to accelerate growth.
- Remuneration frameworks and shareholder disclosures are provided in line with statutory requirements.
- The report emphasizes Vitrafy’s commitment to innovation and market leadership within the cryopreservation field.
- Future outlook projects continued focus on technology commercialization and capitalizing on global opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clever Culture Systems Limited (CC5) ORDINARY FULLY PAID |
Health Care |
$50 |
Application for quotation of securities - CC5
|
5 Aug 2025 8:32AM |
$0.032 |
$0.023 |
fallen by
28.13%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$78 |
Investor Webinar
|
5 Aug 2025 8:32AM |
$0.170 |
$0.320 |
risen by
88.24%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$4,996 |
Historical Financials in USD and H12025 OPEX (Unaudited)
|
5 Aug 2025 8:30AM |
$20.240 |
$14.720 |
fallen by
27.27%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix Pharmaceuticals Limited changed its reporting currency to USD from 1 January 2025 to align with its primary revenue and cost currency.
- Unaudited historical financial information for the years 2023 and 2024 was recast in USD to assist investors ahead of the 2025 interim results.
- Telix expects its Operating Expenditure (OPEX) in H1 2025 to be approximately 36% of revenue, excluding research and development costs.
- The company's expanded operations in the U.S. follow several acquisitions, notably RLS Radiopharmacies, completed on 27 January 2025.
- Revenue from contracts with customers in H1 2024 was USD 239.6 million compared to USD 148.8 million in H1 2023.
- Gross profit for the year ended 31 December 2024 was USD 336.2 million, reflecting a gross margin of 65%.
- Adjusted EBITDA for the full year 2024 was USD 67.4 million, while profit before income tax was USD 37.9 million.
- Net cash from operating activities was USD 27.5 million for the year ended 31 December 2024.
- Telix Pharmaceuticals Limited is focused on the development and commercialization of radiopharmaceuticals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
